CT, MRI, MRCP, and EUS in Pancreatic Evaluation: What's the Difference?

Pancreas-protocol CT: staging and vessel relationships

A standard abdominal CT and a CT performed with a dedicated pancreas protocol are not the same thing. Pancreas-protocol CT uses contrast timed to specific phases to most clearly distinguish pancreatic tissue from the large surrounding blood vessels — particularly the portal vein and superior mesenteric artery/vein.

When a mass is found, this method shows how close it is to these vessels and whether it is encasing or pushing against them, making it a key part of surgical planning. It's also usually the first test used to screen for spread to the liver or lungs.

MRI and MRCP: cyst contents and duct anatomy

Magnetic resonance imaging provides more detailed soft-tissue contrast than CT, which is why it's preferred for showing the internal structure, septations, and wall features of cystic lesions. With the added MRCP sequence, the main pancreatic duct and bile ducts can be shown in detail without any invasive procedure.

For this reason, MRI/MRCP is usually the first advanced test chosen when a cyst or IPMN is suspected, whereas CT's strength stands out when staging a mass. The two methods most often complement each other rather than one replacing the other.

EUS: close-up examination and sampling

In endoscopic ultrasound, an endoscope with an ultrasound probe at its tip is passed through the stomach and duodenum to obtain images from very close to the pancreas. This proximity can reveal millimeter-sized lesions and fine structural details more clearly than CT or standard MRI.

Another key feature of EUS is that tissue or fluid can be sampled with a fine needle during the same procedure. This sampling provides valuable information when the diagnosis remains unclear or when the nature of cyst fluid needs to be determined.

Test — what it answers best — its limitation

• Pancreas-protocol CT — Staging a mass, its relationship to major vessels, spread to distant organs — May not show the internal structure of small cystic lesions or fine duct detail as clearly as MRI/EUS
• MRI / MRCP — Cyst contents, septa/wall features, main pancreatic duct and bile duct anatomy — Takes longer to perform; not suitable for some patients (e.g., certain implants)
• EUS — Close-up examination of millimeter-sized lesions, needle sampling of tissue/fluid when needed — Requires sedation and endoscopy; results depend heavily on the experience of the physician performing it
• ERCP — Relieving obstruction in the bile/pancreatic duct, placing a stent (therapeutic) — Not used routinely for diagnosis; an invasive procedure that itself carries a risk of pancreatitis

Why isn't ERCP a routine diagnostic test?

Endoscopic retrograde cholangiopancreatography (ERCP) is an invasive endoscopic procedure that provides direct access to the bile and pancreatic ducts. Even though its image quality is high, the procedure itself carries a risk of complications such as pancreatitis. For this reason, current practice reserves ERCP not for diagnosis alone but for situations that need a therapeutic step — removing a bile duct stone or placing a stent across a stricture, for example.

Diagnostic questions are mostly answered with non-invasive MRCP or EUS; ERCP generally comes into play afterward, once the treatment step has been clarified.

What order are these tests done in?

As a general rule, the process starts with the least invasive method that provides the broadest information. If a mass is suspected, pancreas-protocol CT is usually done first, with MRI added if needed; if a cyst is suspected, MRI/MRCP is usually chosen directly. EUS comes into play when findings remain unclear or sampling is needed. ERCP is planned as a treatment step once the diagnosis is clear.

This sequence isn't a fixed rule — it's adapted to the patient's clinical picture, prior imaging, and the resources available at the center.